Terry Fox funding supports two research projects


The Terry Fox Research Institute (TFRI) is investing $13.4 million in two established research teams focused on oncolytic viruses and leukemia. The funding flows through TFRI's New Frontiers Program Project Grants, the Terry Fox Foundation's flagship program. An Ottawa-based team led by Dr John Bell, a senior scientist at the Ottawa Hospital Research Institute, will receive $7.5 million to fund its trans-Canada network examining the use of oncolytic viruses as biotherapeutics to treat cancer. The funding includes $500,000 from the Canadian Institutes of Health Research, which assisted TFRI in managing the selection and review of the successful programs. A Vancouver-based team at the BC Cancer Agency will receive $5.9 million to develop new ways of treating aggressive forms of leukemia by creating and using laboratory-built models that mimic human acute leukemia....


Other stories mentioning these organizations, people and topics
Organizations:

Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.